NCT05584826View on ClinicalTrials.gov

MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
CancerAdjustment Disorders
Interventions
DRUG

MDMA

On 2 separate treatment visits, participants will receive dosing of 100 mg MDMA HCl (\~84 mg MDMA) + 40 mg MDMA HCl (\~34 mg MDMA) supplement unless tolerability issues arise from the first dose or the participant declines

Trial Locations (1)

20850

RECRUITING

Sunstone Medical, PC, Rockville

All Listed Sponsors
lead

Sunstone Medical

OTHER